Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study

OBJECTIVE: Fenfluramine has been shown to provide clinically meaningful and statistically significant reductions in convulsive seizure frequency in children and adolescents (aged 2‐18 years) with Dravet syndrome in two randomized, placebo‐controlled clinical trials. The objective of this analysis wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Joseph, Scheffer, Ingrid E., Lagae, Lieven, Nabbout, Rima, Pringsheim, Milka, Talwar, Dinesh, Polster, Tilman, Galer, Bradley, Lock, Michael, Agarwal, Anupam, Gammaitoni, Arnold, Morrison, Glenn, Farfel, Gail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756901/
https://www.ncbi.nlm.nih.gov/pubmed/33078386
http://dx.doi.org/10.1111/epi.16722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756901/
https://www.ncbi.nlm.nih.gov/pubmed/33078386
http://dx.doi.org/10.1111/epi.16722

Ejemplares similares